Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors.
暂无分享,去创建一个
Chinmay Y. Majmudar | H. Al‐Hashimi | D. Wemmer | A. Mapp | S. Rowe | Brian B. Brennan | S. Buhrlage | C. A. Bates | Aaron R. Minter
[1] A. Mapp,et al. Expanding the repertoire of small molecule transcriptional activation domains. , 2009, Bioorganic & medicinal chemistry.
[2] Chinmay Y. Majmudar,et al. Mocr: a novel fusion tag for enhancing solubility that is compatible with structural biology applications. , 2009, Protein expression and purification.
[3] J. Omichinski,et al. NMR structure of the complex between the Tfb1 subunit of TFIIH and the activation domain of VP16: structural similarities between VP16 and p53. , 2008, Journal of the American Chemical Society.
[4] A. Mapp,et al. Assessing the permissiveness of transcriptional activator binding sites. , 2008, Biopolymers.
[5] K. Struhl,et al. A nuclear receptor-like pathway regulating multidrug resistance in fungi , 2008, Nature.
[6] N. Sharma,et al. The Human T-Cell Leukemia Virus Type 1 Tax Protein Confers CBP/p300 Recruitment and Transcriptional Activation Properties to Phosphorylated CREB , 2007, Molecular and Cellular Biology.
[7] J. Nyborg,et al. Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300. , 2007, Journal of molecular biology.
[8] A. Mapp,et al. Transcriptional up-regulation in cells mediated by a small molecule. , 2007, Journal of the American Chemical Society.
[9] T. Kodadek,et al. Design and synthesis of a cell-permeable synthetic transcription factor mimic. , 2007, Journal of combinatorial chemistry.
[10] A. Ansari,et al. A TAD further: exogenous control of gene activation. , 2007, ACS chemical biology.
[11] Bo Liu,et al. Isolation and characterization of coactivator-binding peptoids from a combinatorial library. , 2006, Molecular bioSystems.
[12] M. Carey,et al. A mechanism for coordinating chromatin modification and preinitiation complex assembly. , 2006, Molecular cell.
[13] John S. Satterlee,et al. An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis , 2006, Nature.
[14] Hans‐Dieter Arndt. Small molecule modulators of transcription. , 2006, Angewandte Chemie.
[15] R. Tjian,et al. Coactivator cross-talk specifies transcriptional output. , 2006, Genes & development.
[16] Lawryn H Kasper,et al. Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development , 2006, Molecular and Cellular Biology.
[17] Peter E Wright,et al. Structural Basis for Cooperative Transcription Factor Binding to the CBP Coactivator , 2005, Journal of molecular biology.
[18] Steven Hahn,et al. Targets of the Gal4 Transcription Activator in Functional Transcription Complexes , 2005, Molecular and Cellular Biology.
[19] A. Mapp,et al. Stereochemical promiscuity in artificial transcriptional activators. , 2005, Journal of the American Chemical Society.
[20] T. Kodadek,et al. A potent transactivation domain mimic with activity in living cells. , 2005, Journal of the American Chemical Society.
[21] Jerry L. Workman,et al. Mechanism of Transcription Factor Recruitment by Acidic Activators* , 2005, Journal of Biological Chemistry.
[22] S. Hahn,et al. Function of a eukaryotic transcription activator during the transcription cycle. , 2005, Molecular cell.
[23] R. Roeder,et al. Structural and Functional Characterization of PC2 and RNA Polymerase II-Associated Subpopulations of Metazoan Mediator , 2005, Molecular and Cellular Biology.
[24] R. Roeder,et al. Transcriptional regulation and the role of diverse coactivators in animal cells , 2005, FEBS letters.
[25] Rob Kaptein,et al. Structural properties of the promiscuous VP16 activation domain. , 2005, Biochemistry.
[26] K. Gardner,et al. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Mapp,et al. A small molecule transcriptional activation domain. , 2004, Journal of the American Chemical Society.
[28] Peter E Wright,et al. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. , 2004, Journal of molecular biology.
[29] Michael R Green,et al. In vivo target of a transcriptional activator revealed by fluorescence resonance energy transfer. , 2004, Genes & development.
[30] Frank Eisenhaber,et al. Linking transcriptional mediators via the GACKIX domain super family , 2004, Current Biology.
[31] K. Lumb,et al. NMR mapping of the HIV-1 Tat interaction surface of the KIX domain of the human coactivator CBP. , 2004, Biochemistry.
[32] Thomas Kodadek,et al. Isolation of protein ligands from large peptoid libraries. , 2003, Journal of the American Chemical Society.
[33] Chinmay Y. Majmudar,et al. Targeting the transcriptional machinery with unique artificial transcriptional activators. , 2003, Journal of the American Chemical Society.
[34] K. Lumb,et al. KIX-mediated assembly of the CBP-CREB-HTLV-1 tax coactivator-activator complex. , 2003, Biochemistry.
[35] K. Lumb,et al. Molecular recognition of the human coactivator CBP by the HIV-1 transcriptional activator Tat. , 2003, Biochemistry.
[36] P. Chène. Inhibiting the p53–MDM2 interaction: an important target for cancer therapy , 2003, Nature Reviews Cancer.
[37] Amelia A. Fuller,et al. A concise approach to structurally diverse beta-amino acids. , 2003, Journal of the American Chemical Society.
[38] A. Ansari,et al. Modular design of artificial transcription factors. , 2002, Current opinion in chemical biology.
[39] K. Lumb,et al. Structurally distinct modes of recognition of the KIX domain of CBP by Jun and CREB. , 2002, Biochemistry.
[40] Peter E Wright,et al. Cooperativity in Transcription Factor Binding to the Coactivator CREB-binding Protein (CBP) , 2002, The Journal of Biological Chemistry.
[41] Peter E Wright,et al. Roles of Phosphorylation and Helix Propensity in the Binding of the KIX Domain of CREB-binding Protein by Constitutive (c-Myb) and Inducible (CREB) Activators* , 2002, The Journal of Biological Chemistry.
[42] J. Darnell. Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.
[43] J. Qin,et al. External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[44] Lisa E. Gralinski,et al. Transcriptional Regulation of the mdm2 Oncogene by p53 Requires TRRAP Acetyltransferase Complexes , 2002, Molecular and Cellular Biology.
[45] D. Botstein,et al. Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.
[46] Thomas Kodadek,et al. Recruitment of a 19S Proteasome Subcomplex to an Activated Promoter , 2002, Science.
[47] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[48] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[49] J. Manfredi,et al. Multiple roles of the tumor suppressor p53 , 2002, Current opinion in oncology.
[50] T. Kodadek,et al. The Gal4 Activation Domain Binds Sug2 Protein, a Proteasome Component, in Vivo and in Vitro * , 2001, The Journal of Biological Chemistry.
[51] A. Ansari. Regulating Gene Expression: The Design of Synthetic Transcriptional Regulators , 2001 .
[52] C. J. Jeong,et al. Evidence that Gal11 protein is a target of the Gal4 activation domain in the mediator. , 2001, Biochemistry.
[53] N. L. La Thangue,et al. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. , 2001, Journal of cell science.
[54] J. Workman,et al. Recruitment of HAT Complexes by Direct Activator Interactions with the ATM-Related Tra1 Subunit , 2001, Science.
[55] E. Carreira,et al. A General Solution to the Modular Synthesis of Polyketide Building Blocks by Kanemasa Hydroxy-Directed Nitrile Oxide Cycloadditions. , 2001, Angewandte Chemie.
[56] S. Korsmeyer,et al. MLL and CREB Bind Cooperatively to the Nuclear Coactivator CREB-Binding Protein , 2001, Molecular and Cellular Biology.
[57] P. Pandolfi. Transcription therapy for cancer , 2001, Oncogene.
[58] Dimitris Thanos,et al. Ordered Recruitment of Chromatin Modifying and General Transcription Factors to the IFN-β Promoter , 2000, Cell.
[59] L. Cantley,et al. Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening , 2000, Nature Biotechnology.
[60] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[61] R. Goodman,et al. CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.
[62] S. Ishii,et al. Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein , 2000, Mechanisms of Development.
[63] R. Roeder,et al. Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells. , 2000, Trends in biochemical sciences.
[64] H. Dyson,et al. Structural analyses of CREB-CBP transcriptional activator-coactivator complexes by NMR spectroscopy: implications for mapping the boundaries of structural domains. , 1999, Journal of molecular biology.
[65] M. Uesugi,et al. The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Yaffe,et al. Analysis of an activator:coactivator complex reveals an essential role for secondary structure in transcriptional activation. , 1998, Molecular cell.
[67] T. Kodadek,et al. Small-molecule-based strategies for controlling gene expression. , 1998, Chemistry & biology.
[68] Medeva Ghee,et al. AP-1, CREB and CBP transcription factors differentially regulate the tyrosine hydroxylase gene. , 1998, Brain research. Molecular brain research.
[69] Peter E Wright,et al. Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: A Model for Activator:Coactivator Interactions , 1997, Cell.
[70] H. Masuya,et al. Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[71] A. Levine,et al. Induced alpha helix in the VP16 activation domain upon binding to a human TAF. , 1997, Science.
[72] Raoul C. M. Hennekam,et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.
[73] G. Prestwich,et al. Benzophenone photophores in biochemistry. , 1994, Biochemistry.
[74] A. Kamimura,et al. First Successful Metal Coordination Control in 1,3-Dipolar Cycloadditions. High-Rate Acceleration and Regio- and Stereocontrol of Nitrile Oxide Cycloadditions to the Magnesium Alkoxides of Allylic and Homoallylic Alcohols , 1994 .
[75] Masatoshi Hagiwara,et al. Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.
[76] S. Johnston,et al. Genetic evidence that an activation domain of GAL4 does not require acidity and may form a β sheet , 1993, Cell.
[77] T. Kodadek,et al. The acidic activation domains of the GCN4 and GAL4 proteins are not alpha helical but form beta sheets. , 1993, Cell.